Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06403644Not ApplicableActive Not Recruiting

Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices

Role: lead

NCT07526285Not ApplicableNot Yet Recruiting

Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) for Treatment of Post-Traumatic Stress Disorder (PTSD)

Role: collaborator

NCT05392556Not ApplicableCompleted

Prebiotic and Probiotic Modulation of the Gut Microbiota-gut-brain Axis During Acute Stress

Role: collaborator

NCT07273422Recruiting

Novel Self-charging, Medical-Grade Smart Insoles With AI/ML Edge Computing to Monitor Biometrics.

Role: collaborator

NCT02920528Phase 3Completed

Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain

Role: collaborator

All 5 trials loaded